Our portfolio

Companies we’re proud to stand behind.

A closer look at who we work with, and why we chose to.

Our strategy

How we build the portfolio

We don’t chase trends or diversify for its own sake. Every company in our portfolio is chosen because we believe in the people running it and the long-term potential of the business — regardless of which sector it sits in.

We typically take long-term stakes and stay closely involved, offering experience, access to our network, and capital for future growth phases as the company needs it.

Company profiles

Companies

GCP-Service

GCP-Service is a full-service contract research organisation (CRO) active since 2004. It plans and runs clinical trials for pharmaceutical, biotech and medical device companies, from regulatory affairs, biostatistics and project management to monitoring, data management, medical writing and product vigilance. Its processes are certified to ISO 9001 and ISO 14155, and its experts cover fields such as ophthalmology, dermatology, oncology, aesthetic medicine, neurology and cardiology. More than 600 studies have been conducted. Beyond its CRO work, GCP-Service runs trials as sponsor, invests in medical device start-ups and shares knowledge through training and its YouTube channel.

Skinuvita

Skinuvita enables home phototherapy with medical supervision through an app. It is aimed at chronic inflammatory skin conditions such as psoriasis, atopic dermatitis and hand-eczema. Patients receive a smart UVB therapy device, a control unit for precise dosing and the Skinuvita app, which guides each session while a dermatologist monitors progress. The company was founded in 2021 as a university spin-off, is a CE-marked class IIa medical device under MDR, and was named Startup of the Year at the Bremer Gründungspreis 2024. Costs can be covered for patients insured with partner health insurers.

“The support of GCP Holding was essential to Skinuvita’s success on many levels. From a very early stage of our development, we were treated as equal partners and received exactly the support we needed: a unique combination of funding, mentoring, clinical research support, and quality management coaching.”

— Jan Elsner, Founder & CEO, Skinuvita GmbH

Hilmar Gersie Construcciones y Servicios

Hilmar Gersie is a project management and building company. It accompanies clients from the first plot of land to the finished house, and offers custom projects, new builds and renovations, maintenance and services, and passive houses. The company was founded and is still managed by a German civil engineer with long experience in building, and works with an English- and German-speaking team that controls quality, time and cost. It also specialises in highly energy-efficient homes.

Habric

Habric develops blind Sonar, a headband for blind and visually impaired people. The headband detects nearby obstacles and indicates their position through gentle vibrations on the head, helping wearers sense where objects are as they move. The product is still in development and is being tested together with associations for blind and visually impaired people in several European countries. Pre-orders are coming soon.

“We build blind Sonar with blind and visually impaired people, not just for them. Andreas backed that approach early on and is now helping us prove it in a clinical study.”

— Julian Schenker, Co-Founder & CEO, habric GmbH

Vitadio

Vitadio is a digital therapy for people with type 2 diabetes. The app guides users through small, achievable habits in nutrition, exercise and sleep, with the aim of lowering blood sugar and supporting weight loss, without strict diets or calorie counting. It is listed by the German BfArM as a digital health application (DiGA), so it can be prescribed and is covered by statutory health insurance in Germany. Vitadio works with scientific partners including University Hospital Olomouc and holds ISO 27001 and ISO 13485 certification.

“We founded Vitadio with a clear ambition: to make effective diabetes care available to everyone who needs it. We’re driven by the opportunity to help people take control of their health and live better lives.”

— Jan Šomvársky, Co-founder & CEO, Vitadio

Hair Up Laser

Hair Up Laser is a medical technology start-up developing a non-invasive treatment for hair loss. Its device uses photobiomodulation, a form of low-level laser light therapy, to stimulate the scalp and support hair regrowth, with a focus on androgenic alopecia, which affects both men and women. The company is preparing the clinical validation of its device and the regulatory steps towards CE marking, with the aim of entering the European market.

tio health

tio health develops a digital platform that connects parents and paediatric practices to make healthcare for children more accessible, efficient and effective. Through multilingual, guided questionnaires, parents can share relevant information about their child’s symptoms, medical history and development before an appointment. Paediatricians receive this information in a structured format in German, reducing administrative work, overcoming language barriers and allowing more time for patient care. Alongside this, the tio app supports parents with evidence-based health information, personalised guidance and tools to track their child’s health and development. Developed together with experienced paediatricians and based on established medical guidelines, tio aims to improve healthcare for children while reducing the burden on paediatric practices. The platform is GDPR-compliant and does not replace medical advice.

“At tio, we believe that every child should get the care they need, when they need it – and that parents’ observations are a valuable part of making this possible. Andreas Grund and the entire GCP Holding team have been great supporters of this mission, bringing valuable expertise and experience that helps us move faster and bring tio to more families and healthcare professionals.”

— Raphael Heber, Co-Founder & CEO, tio health

OneTwenty

OneTwenty develops machine-learning technology for diabetes care under the name bioX. bioX powers a learning closed-loop system for automated insulin delivery, a digital twin engine that models an individual’s metabolism, and algorithms that improve the accuracy of glucose and other biomarker sensors. The models were built on more than 4.4 million hours of continuous glucose data. The company grew out of machine-learning research that began in 2018 and was incorporated as OneTwenty AG in 2022. bioX is an investigational solution and is not yet commercially available.

“Clinical studies are the decisive step for OneTwenty right now, and with GCP we’ve gained an investor who knows this terrain inside out. Andreas Grund brings entrepreneurial experience and a network we could only have dreamed of, and having him on our side makes the road ahead feel a lot less lonely.”

— Michael Rottmann, Co-Founder & CEO, OneTwenty AG

Fund investments

Funds

Capnamic

Capnamic Bremen I is a €30.3 million deep tech venture capital fund that invests in seed and Series A start-ups. It backs technology-driven founders in a range of verticals, among them maritime economy, logistics, food and beverage, health and space. The fund supports outstanding founders whose technologies create real value in these industries. Capnamic Bremen I is managed by Capnamic Ventures.

“We are unreasonably committed to the unreasonable few: the founders who build deep technology with the potential to change entire industries. Partners like GCP Holding, who share this long-term view, make it possible for us to support them from the very first steps.”

— Prof. Dr. Christian Horneber, Managing Partner Bremen, Capnamic Ventures

5P Future of Health

5P Future of Health is a super early-stage investment boutique focused exclusively on digital health and health tech start-ups. It invests in ideas along 5P medicine (prevention, predictive medicine, participative health, precision medicine and prolonged health), with the goal of moving from sick-care to health-care. Its team of general partners, partners and venture partners covers technology, venture strategy, deal sourcing and medicine. For founders in the pre-seed and seed phase it offers an incubation programme, strategic advice and introductions to clients, partners and talent.

Feast Ventures

Feast Ventures is an early-stage venture fund backing founders who are reshaping how we grow, eat and live. The fund invests at the nexus of agriculture, food and health, targeting early-stage investments (Seed focus), particularly in Europe. It focuses on three verticals: Grow Better (smarter, leaner agricultural inputs and data-driven farm management), Eat Better (ingredient and supply-chain innovation that makes food more productive, resilient and appealing) and Live Better (nutrition solutions that deliver measurable health outcomes). Feast pairs deep sector networks with hands-on support to help category-defining companies scale from their first cheque to market leadership.

“Having GCP Holding alongside us means more than capital – it’s an ecosystem partner who shares our conviction that the future of food and health can be built in Europe, by founders bold enough to start early.”

— Benedikt Stöckert, Managing Partner, Feast Ventures